Introduction
============

Hypertension is a complex multifactorial disorder with genetic, environmental and demographic factors contributing to its prevalence [@B1]. Studies have shown that about 90-95% of cases are primary hypertension, with high blood pressure and without recognizable or explicable risk factors [@B2]. Hypertension is related to high blood pressure which is one of the contributing factors for the onset of macrovascular complications such as myocardial infarction, stroke and end-stage renal disease. Components of the renin-angiotensin-aldosterone system (RAAS) are the important factors that regulate body\'s blood pressure homeostasis and dysfunction of this system leads to hypertensive phenotypes [@B3]-[@B5]. There are also several associated causes responsible for the instigation of high blood pressure for example, age, obesity and factors like alcohol consumption, smoking [@B6]-[@B8]. However, genetic factors also account for the initiation of variable ranges of high blood pressure in different populations. Also, genes of RAAS are of particular interest to find out the gene loci associated with hypertension. Among them, renin has always got top priority for being the key enzyme [@B9]-[@B11].

Animal model studies have clearly demonstrated that development of hypertension is associated with the variations in blood pressure controlling renin gene [@B12]. To find out an association of genetic predisposition with hypertension in human, several polymorphisms within renin gene or near its promoter sequences have been reported with inconsistent results [@B13]-[@B16]. *Bgl*I dimorphism [@B15] and *Bgl*I B allele in renin gene [@B17] was found to be associated with increased risk of developing essential hypertension, while Naftilan et al. [@B14] did not find such relationship. Study with Chinese population revealed that hypertension is more strongly associated with *Hind*III polymorphisms of renin gene than *Bgl*I [@B18]. Another study conducted among the rural residents of Beijing, China and urban Tibetan individuals confirmed that prevalence of hypertension is related to *Taq*I polymorphisms of 4063 bp upstream of renin gene promoter [@B19]. Moreover, *Mbo*I dimorphism in intron 9 of the human renin gene is strongly associated with essential hypertension [@B20].

Developing countries are more likely to face burden of chronic non-communicable diseases in near future due to increased life expectancy as well as demographic transition [@B21]. Of these diseases, hypertension is one of the most important threatable causes of mortality and morbidity in the elderly population [@B21]. On the other hand, representative data on the prevalence of hypertension in a Bangladeshi population are insufficient. A study reported that prevalence of hypertension in adults is 11.3% in Dhaka only [@B22]. Further, migrant Bangladeshis had greater risk for hypertension compared to the Europeans and other migrant South Asians [@B23]. It is important to reveal the molecular mechanism of blood pressure regulation. This will help in pharmacological aspects concerning the fundamental gene therapy based specific treatment to the needs of the patient. However, studies on the possible genetic predisposition to hypertension among Bangladeshi population in the context of renin gene polymorphisms are lacking. Thus, the objectives of this study was to investigate the pattern of renin gene polymorphism among the Bangladeshi hypertensive and normotensive subjects by analyzing the PCR-based *Bgl*I, *Taq*I and *Mbo*I restriction fragment length polymorphisms.

Methods and Materials
=====================

Study subjects and collection of blood samples
----------------------------------------------

A total of 66 hypertensive unrelated Bangladeshi individuals who attended in the outdoor of the cardiology department of Bangabandhu Sheikh Mujib Medical University (BSMMU) and Appollo hospitals, Dhaka were enrolled in this study. Control subjects (n = 58) such as university and hospital personnels, office staffs and post-doc fellows willingly donated their blood for the study. The study was conducted according to the guidelines set by the ethical review board of the faculty of Biological Science, University of Dhaka. Blood pressure of each individual was measured at sitting position. People having systolic blood pressure (SBP) ≥140 mmHg and diastolic blood pressure (DBP) ≥ 90 mmHg (according to World Health Organization) were considered as the hypertensive subjects. Status of the patients or grading of hypertension considering the severity of patients was not taken into consideration in the study. Patients with diabetes, chronic kidney disease or any other major renal diseases, hepatitis B virus surface antigen (HbsAg) positive were excluded from this study. The control subjects had no major health complications. Five to six milliliter of blood was collected from each individual. Plasma samples were used to analyze total cholesterol using standard enzymatic-colorimetric methods.

Rationale behind choosing *Bgl*I, *Mbo*I and *Taq*I restriction sites
---------------------------------------------------------------------

The human renin gene consists of 10 exons and 9 introns [@B24]. The *Bgl*I and *Mbo*I restriction sites are present at the first and ninth introns of renin gene, respectively and *Taq*I restriction site is present at the 4063 bases upstream of the promoter sequence. Variation in these sites, especially in *Bgl*I and *Taq*I, (considered to be the transcription factor binding sites) could affect the functional association of renin gene with fluid homeostasis i.e., blood pressure leading to hypertension. Besides, different literatures regarding the association of renin gene polymorphisms with hypertension among Asians, Europeans and Americans have indicated that almost all of the studies have been carried out giving emphasis on *Bgl*I, *Mbo*I and *Taq*I restriction fragment renin gene polymorphisms. Though some of them found strong association between polymorphism and hypertension, however, many of them did not. As this is the first study on renin gene polymorphism among Bangladeshi population, we were also interested concerning *Bgl*I, *Mbo*I and *Taq*I restriction sites present in renin gene to observe their association with hypertension.

Extraction of genomic DNA
-------------------------

Genomic DNA was extracted by organic extraction procedure from cellular fraction of blood [@B25]. The quantity and level of purification of extracted DNA was measured using NanoDrop (NanoDrop1000, US). The average concentration of extracted DNA was 357±17.88 ng/μL. This method generates purified DNA with an average value of 260/280 ratio was 1.79 and of 260/230 ratio was 1.57 in case of total study subjects. Extracted DNA samples were subjected to agarose gel electrophoresis to determine the quality of DNA and band in Fig. [1](#F1){ref-type="fig"}a and [1](#F1){ref-type="fig"}b did not show any variation.

Polymerase chain reaction and restriction digestion of PCR products
-------------------------------------------------------------------

To perform polymerase chain reactions, 50 μL of reaction mixture was prepared using 10 mM dNTPs, 100 μM of forward and reverses primer (specific for renin gene) and 1000 Unit of *Taq* DNA polymerase. PCR conditions applied for the amplification of respective regions have been presented in Table [1](#T1){ref-type="table"}. PCR products were subjected to restriction digestion using *Bgl*I, *Taq*I and *Mbo*I according to the manufacturer\'s recommended protocol with minor modifications. Briefly, 2.0μL restriction enzyme buffer (10X buffer), 0.4μL bovine serum albumin (10 μg/ μL), 0.6μL restriction enzyme (1000 Unit), 7 μL deionized water and 10 μL of PCR product (1μg/μL) were mixed gently and incubated for 2 hours at 37°C for restriction digestion by *Bgl*I and *Mbo*I and, 65°C for *Taq*I digestion. Digested products were evaluated by agarose gel electrophoresis using 100 bp ladder as standard.

Data analyses
-------------

The results were expressed as mean (±SD) and to compare the differences between different variables from the control and hypertensive subjects, independent Student\'s t-test was performed. Multivariate analyses were also performed using different parameters as independent variables (e.g., age, gender, SBP, DBP) to find out their association with genotypic variations of renin gene. A p value of less than 0.05 was considered significant. Allele frequencies were determined by Hardy-Weinberg equilibrium calculator using the method developed by Rodriguez et al. [@B26].

Results
=======

Anthropometric data of the study subjects
-----------------------------------------

The anthropometric and biochemical details of the study subjects are presented in Table [2](#T2){ref-type="table"}. The mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) were significantly higher (*P*\< 0.001) in the hypertensive (150.5±15.8 and 94.0±13.9 mmHg, respectively) compared to that of the normotensive subjects (115.0±5.5 and 77.2±4.5 mmHg, respectively). The levels of total plasma cholesterol, random blood glucose, plasma creatinine and total protein of the normotensive and hypertensive subjects were 166.8±38.1 vs 178.8±5.6 mg/dL; 112.9±10.1 vs 120.9±9.2 mg/dL; .0.73±0.18 vs 0.99±0.08 mg/dL and 6.7±0.85 and 6.8±0.90 mg/dL, respectively.

Evaluation of products derived from PCR and restriction digestion
-----------------------------------------------------------------

Both PCR and restriction enzyme digested products were subjected to run on a 1.8% agarose gel Fig. [1](#F1){ref-type="fig"}c, [1](#F1){ref-type="fig"}d and [1](#F1){ref-type="fig"}e represent the PCR products of renin gene containing *Bgl*I, *Taq*I and *Mbo*I polymorphisms, respectively and Fig. [1](#F1){ref-type="fig"}f, [1](#F1){ref-type="fig"}g and [1](#F1){ref-type="fig"}h represent the digested PCR products with respective restriction enzymes. Sizes of the DNA bands were confirmed using 100 bp DNA ladder (Promega, USA).

Genotypic and allelic frequencies
---------------------------------

The respective frequency of the *Bgl*I, *Taq*I and *Mbo*I genotype in study subjects is given in Table [3](#T3){ref-type="table"}. For *Bgl*I and *Taq*I genotype distribution, hypertensive subjects (*Bgl*I: χ*^2^* =6.66,*df*=2, P\<0.05; *Taq*I: χ*^2^* = 10.28, *df* =2, P\<0.005) significantly deviate from Hardy-Weinberg Equilibrium law compared to normotensive subjects (*Bgl*I: χ*^2^* =0.51, *df* =2, P\>0.05; *Taq*I: χ*^2^* = 0.2, *df* =2, P\>0.05). On the other hand, with respect to *Mbo*I polymorphisms of renin gene, only normotensive subjects deviate from the law (patients: χ*^2^* =1.28, *df* =2, P\>0.05; vs controls: χ*^2^* =6.81, *df* =2, P\<0.01). Frequency distribution among the study subjects have been shown in Table [4](#T4){ref-type="table"}. Common T allele was found to be prevalent (T frequency = 0.86, t frequency = 0.14) for *Taq*I, but rare alleles b and m were more frequent for both *Bgl*I (b frequency = 0.69, B frequency = 0.31) and *Mbo*I (m frequency = 0.80 M frequency = 0.20) polymorphisms, respectively among total study subjects.

Renin *Bgl*I, *Taq*I and *Mbo*I genotype distributions were evaluated in relation to the levels of SBP and DBP (Table [5](#T5){ref-type="table"}). There was no statistically significant difference between blood pressure values in relation to any of the three genotypes among either normotensive or hypertensive subjects. Neither the pooled data of both normotensives and hypertensives could show any significant association between the genotype distributions with the blood pressure.

Discussion
==========

The screening of variations within the renin gene to assess its linkage with high blood pressure i.e., hypertension was the main objective of the present study. The linkage and sib-pair linkage analysis and association studies have laid the ground work to evaluate the effects of genetic variations in renin gene in human population. However, the results of various sib-pair analyses have been inconsistent in clearly linking nucleotide variations of renin gene as the appropriate cause of hypertension [@B27]-[@B29]. Numerous studies in different ethnic population have focused attention on renin intronic polymorphisms, such as *Hind*III, *Bgl*I and *Mbo*I as well as the promoter *Taq*I polymorphism that varied greatly among different reports [@B13]-[@B20], [@B30]-[@B38]. To our knowledge this is the first study carried out to determine the renin gene restriction fragment length polymorphism among Bangladeshi hypertensive and normotensive subjects. This study revealed that homozygosity (both for common and rare alleles) was common in renin gene regarding*Bgl*I (bb=48.4%, Bb=37.9%, BB=13.7%, χ*^2^* =1.91, P\>0.05), *Taq*I (TT=81.5%, Tt=14.5%, tt=4.0%, χ*^2^* =7.50, P\<0.01) and *Mbo*I (mm=63.7%, Mm=32.3%, MM=4.0%, χ*^2^* =0.00, P\>0.05) polymorphisms among total population (Table [3](#T3){ref-type="table"}).

Renin gene locus has been studied for essential hypertension using hypertensive rat models (12, 39\]. In human, the association of*Bgl*I dimorphism in renin gene with hypertension in different populations [@B15], [@B20], [@B32] has been demonstrated, while others fail to establish such association [@B14], [@B30]. On the other hand, Berge and Berg [@B31] in a study with Norwegian population demonstrated that *Bgl*I restriction fragment length polymorphism at the renin locus has neither the \"level gene\" nor \"variability gene\" effects on blood pressure. Allelic frequency of *Bgl*I renin gene polymorphism in present study subjects (either hypertensive or normotensive) showed that b allele (rare homozygous) was more prevalent compare to B allele (common homozygous) whereas, a meta-analysis of the case-control association studies with four populations demonstrated that renin gene *Bgl*I B allele is associated with increased risk of developing essential hypertension [@B17].

*Taq*I polymorphism is located in 4063 bases upstream of renin gene and change in single nucleotide may prevent its expression. The presence of a *Taq*I site in renin gene has been reported to be correlated with lower values of plasma renin activity and higher diastolic blood pressure [@B32]. Studies [@B19], [@B38] proposed a strong association of *Taq*I polymorphism with hypertension and found that the frequencies of *Taq*I t allele were almost similar in two groups of Chinese study population which were lower compared to Caucasian European (13.75%) and Afro-Caribbean (28.45%) populations [@B40], [@B41]. In current study, the frequency of T allele was higher than the frequency of t allele and showed homozygosity (TT) as genotype frequency follows the Hardy-Weinberg equilibrium law. Our findings revealed that genotype frequency with rare homozygous (tt genotype) were lacking in healthy subjects who had normal blood pressure compared to those 6.0% hypertensive subjects.

The distribution of *Bgl*I and *Taq*I renin gene frequencies in the normotensive subjects were found to be in agreement with Hardy-Weinberg equilibrium, which indicated suitable selection of study subjects. Ahmad et al. [@B20] and Frossard et al. [@B32] also found that the genotype frequencies of their normotensive subjects followed Hardy-Weinberg equilibrium. On the other hand, the genotype distribution in the hypertensive group of the present study did not follow the equilibrium rule. This disequilibrium in this group of study subjects could be due to the presence of other loci that might be close to either of the *Bgl*I or *Taq*I polymorphic sites which have strong influence on blood pressure and are strongly linked to the these sites. Also, it should be considered that being a part of the intronic sequences these sequences might be very unlikely to have produced such a strong effect by their own. In the light of this groundwork, it could be portrayed that associations of genotype frequencies of *Bgl*I and *Taq*I renin gene polymorphisms with SBP and DBP are lacking in the study subjects (Table [5](#T5){ref-type="table"}) though the SBP and DBP varied significantly between normotensive and hypertensive subjects (Table [2](#T2){ref-type="table"}).

Due to its location within intron 9, *MboI* RFLP probably does not represent a functional genetic variation. However, genetic variation in this region showed strong positive association with hypertension in different population groups [@B31], [@B33] while others did not find such association [@B36], [@B42]. Okura *et al*. [@B37] were the first to show a positive association between renin gene*Mbo*I RFLP and essential hypertension in Japanese population using linkage disequilibrium with this site or in a nearby gene. One of the possible explanations for this variable pattern of association could be the involvement of more than one gene, with none of the involved genes having a strong influence or penetrance, as is expected for a complex polygenic disorder. Frossard et al. [@B31], [@B32] reported frequencies of 0.64 and 0.36 for the *Mbo*I G and *Mbo*I A alleles in normotensive subjects, whereas the allele frequencies in the hypertensive group were 0.49 and 0.51, respectively. In the present study, the allelic frequencies were 0.79 and 0.80 for m and 0.21 and 0.20 for M alleles, respectively for normotensive and hypertensive subjects. In this case, the *Mbo*I genotype frequencies of hypertensive subjects followed the Hardy-Weinberg Equilibrium law while the normotensive subjects did not follow this rule. Interestingly, the observed frequency of MM genotypes (homozygous for common allele at each locus) were lacking among the normotensive subjects enrolled in the present study while 6.0% of the hypertensive subjects showed such genotypic frequency. Moreover, we did not find any association between the *Mbo*I genotypic frequencies of the normotensive and hypertensive subjects with their respective SBP and DBP (Table [5](#T5){ref-type="table"}).

Genetic profiling of the functional genes not only helps to investigate a specific disease but also to understand the disease propensity within a particular population that may ultimately be of assistance to the clinicians and physicians for prescribing personalized medicine. Brugts et al. in their series of articles [@B43]-[@B46] suggested a broad description of the role of ACE inhibition in the treatment of patients with atherosclerosis. In a substudy of the well-described EUROPA trial with 9454 patients suffering from stable coronary artery disease [@B47], a genetic analysis was performed (PERGENE study). All these data within their limitations serve as substitute for the functional variant which are mostly rare and are not well covered by traditional genome-wide association studies.

Previous study in Bangladeshi hypertensive population demonstrated that among the three DD, II and ID angiotensin converting enzyme (ACE) gene variants, the DD genotype was associated with the highest value of the mean systolic blood pressure and mean diastolic blood pressure in men, but not in women [@B48]. Despite the considerable controversy regarding the existence and importance of ethnic differences in genetic effects for complex diseases, it seems evident that genetic markers for proposed gene-disease associations vary in frequency across populations. Thus, it is important to construct a database of polymorphisms related to hypertension in each ethnic group as suggested by Izawa et al. [@B49]. In humans, elevated blood pressure is associated with increased risk of vascular diseases including myocardial infarction, stroke and coronary artery disease. The variance in blood pressure and its regulation followed by cardiovascular disease susceptibility within populations sharing a common environment indicates that there are genetic as well as cultural determinants of risk [@B50]. Some ethnic groups may be at particular risk of high blood pressure exposed to the same urban environment suggesting involvement of genetic factors. While, changes in lifestyle predominantly the diet and physical activity play an important role in the growing rates of hypertension leading to cardiovascular related complications in developing countries [@B50]. The Asian Indians residing in Singapore have three times higher rates of myocardial infarction than that of Chinese population despite exposure to a similar environment [@B51]. On the other hand, individuals within the same family, may become hypertensive due to different combinations of genes or due to exposure to different environment including life style, dietary habit or lack of physical activity [@B52]. Thus, it has been suggested that the possible reasons accounting for the controversy regarding ethnic differences are neither only for genetic variations nor for other risk associated factors alone rather due to complex interplay between environment, diet, physical activity and genetic variations [@B53].

It is indeed a matter of argument regarding the fact that why Bangladeshi people are lacking an association between the renin gene polymorphisms and hypertension in the current study while other Asian people like Chinese, Japanese, and United Arab Emiratis displayed such association. Different studies postulated that South Asians have highest levels of subclinical atherosclerosis than the Chinese [@B54] and among the South Asians, Bangladeshis have lowest rate of hypertension than Indians and Pakistanis [@B55]. These studies clearly demonstrate that neither the genetic nor the other associated factors alone play role in initiating hypertension with increased blood pressure along with different cardiovascular associated phenotypic expression in Bangladeshi people compare to other Asian people; even compare to other South Asian Indians and Pakistanis. Interestingly, contrasting results regarding the association of *Mbo*I restriction fragment length polymorphism of renin gene have been reported even in the same Japanese population [@B36], [@B37]. Even with the small genetic diversity, Japanese people showed two clusters with different genotypic variations [@B56]-[@B58] which might be the reason of two different *Mbo*I renin gene polymorphism data [@B36], [@B37]. However, rather than excluding the possibility of Indo-Aryan migration [@B59], different studies suggest that the genetic affinities of both Indian ancestral parts are the result of multiple gene pools that flows over the course of thousands of years, with Indo-Aryan extension into the subcontinent [@B60]. Thus, these accumulating data suggest that genetic diversity along with environmental, dietary, cultural as well as genome-wide signals of positive selection from the ancestors might have collectively contributed to the phenotypic diversity in South Asians especially in Bangladeshi people.

The present study has to be taken under consideration within the context of its limitations. It is to mention here that this research work only deals with the association study (irrespective of gender) between blood pressure and the genetic variation of the 3 restriction sites within the renin gene and near its promoter sequence. However, multivariate analyses using age and gender as independent variable respectively also revealed lack of association of renin gene polymorphism with blood pressure. Here, we report that, Bangladeshi hypertensive subjects did not show any distinct pattern of renin gene polymorphisms compared to their healthy counterparts with regard to their genotypic and allelic frequencies, though the rare homozygous in case of *Taq*I (tt genotype) and common homozygous in case of *Mbo*I (MM genotype) are lacking in the normotensive subjects.
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![Agarose gel electrophoresis showing the genomic DNA and PCR products of renin gene having different polymorphisms. Figures a and b represent the genomic DNA extracted from both control and patient subjects, respectively. Figures c, d and e represent PCR products containing *Bgl*I, *Taq*I and *Mbo*I polymorphisms of renin gene. Figures f, g and h represent the restriction digestion products of amplified region using *Bgl*I, *Taq*I and *Mbo*I restriction enzymes respectively. Here, BB, Bb and bb; TT, Tt and tt; and MM, Mm and mm represent three different genotypes of *Bgl*I, *Taq*I and *Mbo*I RFLP of renin gene; M (marker) represents 100 bp ladders. In case of *Bgl*I polymorphism, size of digested PCR products are 515 bp and 257 bp; for *Taq*I polymorphism these are 570 bp and 394 bp; for *Mbo*I polymorphism these are 171 bp and 79 bp.](jgenv02p0045g001){#F1}

###### 

Conditions applied to perform polymerase chain reaction for the determination of different polymorphisms of renin gene.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Sequence site in renin gene                        Primer sequences\                           PCR conditions                                      Size of PCR products (bp)
                                                     Forward primer (FP) & Reverse primer (RP)                                                       
  -------------------------------------------------- ------------------------------------------- --------------------------------------------------- ---------------------------
  4063 bases upstream of start codon of renin gene   FP: 5\'GCTGTCTTCTGGTGGTACTGCC3\'\           95°C-5m (95°C-45s 60°C-30s 72°C-1m30s)×30 72°C-6m   964
                                                     RP:5\'TGCTGGCCATGAACTGGTTCTAGC3\'                                                               

  within intron 1 of renin gene                      FP:5\'GGGGAAGCAGCTTGATATCGTGG3\'\           95°C-5m (92°C-30s 60°C-30s 72°C-30s)×30 72°C-4m     772
                                                     RP: 5\'CTAGGCTGGAGCTCAAGCGATC3\'                                                                

  within intron 9 of renin gene                      FP: 5\'GAGGTTCGAGTCGGCCCCCT3\'\             94°C-5m (94°C-30s 68°C-30s 72°C-30s 72°C-5m)×30     250
                                                     RP: 5\'TGCCCAAACATGGCCACACAT3\'                                                                 
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Anthropometric and biochemical data of control and hypertensive subjects.

  ----------------------------- -------------- -----------------
  Total protein mg/dL           6.7 ± 0.85     6.8 ± 0.90^b^
  Creatinine mg/dL              0.73 ± 0.18    0.99 ± 0.08^b^
  Random plasma glucose mg/dL   112.9 ± 10.1   120.9 ± 9.2^b^
  Total Cholesterol mg/dL       166.8 ± 38.1   178.8 ± 5.6^b^
  DBP mmHg                      77.2 ± 4.5     94.0 ± 13.9^a^
  SBP mmHg                      115.0 ± 5.5    150.5 ± 15.8^a^
  BMI                           21.1 ± 8.5     23.5 ±2.4^b^
  Age years                     46.2 ± 5.6     35.3 ± 7.9
  Gender M/F                    38/20          47/19
  Sample size                   58             66
  Subjects                      Normotensive   Hypertensive
  ----------------------------- -------------- -----------------

^a^p \< 0.001 (SBP and DBP: hypertensive vs normotensive). ^b^ Not significant.

###### 

Genotype distribution of *Bgl*I, *Taq*I and *Mbo*I RFLP of renin gene in both control and hypertensive subjects.

                              Study subjects               
  --------------------------- ---------------- ----------- -----------
  *Bgl*I genotype frequency                                
  BB                          13.7 (17)        12.1 (7)    15.2 (10)
  Bb                          37.9 (47)        50.0 (29)   31.8 (21)
  bb                          48.4 (60)        37.9 (22)   53.0 (35)
  *Taq*I genotype frequency                                
  TT                          81.5 (101)       91.4 (53)   77.3 (51)
  Tt                          14.5 (18)        8.6 (5)     16.7 (11)
  Tt                          4.0 (5)          0           6.0 (4)
  *Mbo*I genotype frequency                                
  MM                          4.0 (5)          0           6.0 (4)
  Mm                          32.3 (40)        41.4 (24)   28.8 (19)
  Mm                          63.7 (79)        58.6 (34)   65.2 (43)

###### 

Distribution of allele frequencies of *Bgl*I, *Taq*I and *Mbo*I renin gene polymorphisms in normotensive and hypertensive subjects.

  Alleles               All        Normotensive   Hypertensive   
  --------------------- ---------- -------------- -------------- ------
  *Bgl*I polymorphism                                            
                        B-allele   0.33           0.37           0.31
                        b-allele   0.67           0.63           0.69
  *Taq*I polymorphism                                            
                        T-allele   0.89           0.96           0.86
                        t-allele   0.11           0.04           0.14
  *Mbo*I polymorphism                                            
                        M-allele   0.20           0.21           0.20
                        m-allele   0.80           0.79           0.80

###### 

Values of SBP and DBP (mean±SD) were set apart according to the renin *Bgl*I, *Taq*I and *Mbo*I genotypes. Parentheses in each cell indicate the number of the participants.

  Genotypes             Systolic blood pressure   Diastolic blood pressure                                                              
  --------------------- ------------------------- -------------------------- -------------------- ----------------- ------------------- -------------------
  *Bgl*I polymorphism                                                                                                                   
  BB                    120.25±5.73 (7)           145 ± 12.9 (10)            134.0±15.65 (17)     78.0 ± 2.94 (7)   92.5 ± 10.41 (10)   86.05±10.11 (17)
  Bb                    120.7 ± 7.36 (29)         163.33±8.16 (21)           135.32±8.2 (50)      77.0±5.0 (29)     105.0±6.0 (21)      88.64±3.39 (50)
  bb                    151.67±12.5 (22)          116.0±11.32 (35)           144.79±7.96 (57)     76.67±4.57 (22)   101.33±8.95 (35)    92.07±4.09 (57)
  *Taq*I polymorphism                                                                                                                   
  TT                    117.95±7.1 (53)           155.91±15.85 (51)          117.95±20.99 (104)   76.86±3.53 (53)   102.0±13.54 (51)    76.86±13.61 (104)
  Tt                    119.0± 12.72 (5)          148.57±14.63 (11)          142.57±20.19 (16)    75.5±6.36 (5)     95.0 ±12.91 (11)    93.71±13.78 (16)
  Tt                    0                         151.67±10.41 (4)           151.67±10.41 (4)     0                 103.33±6.66 (4)     103.33±6.66 (4)
  *Mbo*I polymorphism                                                                                                                   
  MM                    0                         146.33±11.80 (4)           146.33±11.80 (4)     0                 95.67±5.1 (4)       95.67±5.1 (4)
  Mm                    120.67±8.96 (24)          146.67±20.82 (19)          120.67±8.96 (43)     77.0±6.1 (24)     98.33±14.43 (19)    77.0±6.08 (43)
  mm                    122.0±6.24 (34)           143.33±5.77 (43)           120.0±6.24 (77)      78.0±1.73 (34)    94.33±1.15 (43)     78.0±1.73 (77)

NT: Normotensive and HT: Hypertensive subjects.
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